Abstract
Chronic benign pleural effusion (BPE) is a rare complication of concurrent chemoradiotherapy (CRT) for inoperable stage IIIA non-small-cell lung cancer (NSCLC). This report presents three cases of BPE, the workup to differentiate this benign condition from recurrence of cancer and recommends a pleural biopsy as part of the diagnostic process. These inflammatory exudates often remain indolent, and may not require drainage or surgical intervention. In the absence of clinical, radiological and pathological evidence of recurrent disease, we recommend clinicians manage these patients expectantly, using regular clinical assessment and imaging. Internal Medicine Journal
| Original language | English |
|---|---|
| Pages (from-to) | 218-221 |
| Number of pages | 4 |
| Journal | Internal Medicine Journal |
| Volume | 45 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 1 Feb 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Benign pleural effusion
- Case series
- Concurrent chemoradiotherapy
- Non-small-cell lung cancer
- Stage III inoperable
Fingerprint
Dive into the research topics of 'Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver